Abstract
Knowledge of xanthogranuloma (XG) of the sellar region comes from short series or single cases. We performed a systematic review, using the PubMed, Web of Science, Embase, Scopus, eLibrary, and BIOSIS Preview databases, of all cases reported from 2000 to the present. We also describe one unreported patient treated in our institution. A search of the literature revealed that of 71 patients 50.7% were male and that mean age at diagnosis was 34.7 ± 19.2 years old. Median time from clinical onset until diagnosis was 7 (3–21) months. Hypopituitarism (70.4%), visual disorders (64.7%), headache (53.5%), and polyuria-polydipsia (28.2%) were the most common symptoms. On MRI, median tumor size was 20 (16–29) mm, while 71.8% were sellar/suprasellar and less frequently exclusively suprasellar (15.5%) or sellar (12.7%). On T1-weighted imaging, XG was hyperintense in 76.3% of patients, while it showed variable appearance on T2-weighted imaging. The tumor showed cystic features in 50.7%, gadolinium enhancement in 45.1%, and calcification in 22.5% of patients. All patients underwent surgery (77.4% transphenoidal approach and 18.3% craniotomy), with hypopituitarism (56.4%), diabetes insipidus (34.5%), and visual defects (7.3%) being the most common complications. Total/subtotal resection was achieved in 93.5%, while the tumor was partially removed in 6.6%. Median follow-up was 24 (6–55) months and no tumor recurrence or remnant growth was reported in 97.5% of cases. In conclusion, XG affects the younger population, manifested by hormonal deficit and mass effect symptoms. Surgery is safe and offers excellent outcomes, though hypopituitarism is frequent post-surgery. Tumor recurrence or remnant growth is rare and radiological surveillance is a good option for patients with remnant lesions.
Similar content being viewed by others
Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Lopes MBS, Asa SL, Kleinschmidt-DeMasters, BK, Mete O, Osamura RY, Villa C (2021) Pituitary adenoma/pituitary neuroendocrine tumour. In: International Agency for Research on Cancer, 5th ed, vol 6. Central Nervous System Tumours, Lyon, pp 406–14. https://publications.iarc.fr/601
Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382:937–950. https://doi.org/10.1056/NEJMra1810772
Kaltsas GA, Kolomodi D, Randeva H, Grossman A (2019) Nonneuroendocrine neoplasms of the pituitary region. J Clin Endocrinol Metab 104:3108–3123. https://doi.org/10.1210/jc.2018-01871
Famini P, Maya MM, Melmed S (2019) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633–1641. https://doi.org/10.1210/jc.2011-0168
Isaacson B (2015) Cholesterol granuloma and other petrous apex lesions. Otolaryngol Clin North Am 48:361–373. https://doi.org/10.1016/j.otc.2014.12.009
WHO classification of tumours Editorial Board (2021) International Agency for Research on Cancer, 5th ed, vol 6. Central Nervous System Tumours, Lyon. https://publications.iarc.fr/601
Ahmetgjekaj I, Harizi E, Rahman A, Hyseni F, Nasir F, Decka A, Rahman M, Shemsi K, Saliaj K, Akram S, Kola I, Musa J (2022) Giant cholesterol granuloma of petrous apex. Radiol Case Rep 17:1220–1224. https://doi.org/10.1016/j.radcr.2021.12.046
Shirataki K, Okada S, Matsumoto S (1988) Histopathological study of the ‘“cholesterol granuloma reaction”’ in the sellar and juxtasellar tumors. No To Shinkei 40:133–139
Nagatani K, Waga S, Takeuchi J, Takebe Y, Hohda K, Hirano A (1990) Multiple intracranial xanthogranulomas-case report. Neurol Med Chir (Tokyo) 30:960–965. https://doi.org/10.2176/nmc.30.960
Paulus W, Honegger J, Keyvani K, Fahlbusch R (1999) Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 97:377–382. https://doi.org/10.1007/s004010051001
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–225; discussion 226–9. https://doi.org/10.1093/jnen/61.3.215
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100. https://doi.org/10.1371/journal.pmed.1000100
Alharbi A, Alkhaibary A, Alaglan A, Khairy S, Alkhunaizi Z, AlSufiani F, Alassiri AH, Alkhani A (2022) Sellar xanthogranuloma: a diagnostic challenge. Surg Neurol Int 13:76. https://doi.org/10.25259/SNI_1180_2021
Ayadi K, Gallaoui S, Ben Nsir A (2021) Pituitary apoplexy, but not as we thought: a xanthogranuloma rather than an adenoma. Lancet 398(10311):e16. https://doi.org/10.1016/S0140-6736(21)01898-5
Cheng D, Yang F, Li Z, Qv F, Liu W (2021) Juvenile xanthogranuloma of the sellar region with a 5-year medical history: case report and literature review. Pediatr Neurosurg 56:440–447. https://doi.org/10.1159/000515517
Shao X, Wang C, Min J (2020) Xanthogranuloma of the sellar region: a case report. Medicine (Baltimore) 99:e22619. https://doi.org/10.1097/MD.0000000000022619
Pilonieta M, Martin M, Revuelta Barbero JM, Hardesty DA, Carrau RL, Otto BA, Otero J, Ghalib L, Prevedello DM (2020) Sellar cholesterol granuloma mimicking cystic sellar lesions: a report of three cases and literature review. World Neurosurg 144:250–255. https://doi.org/10.1016/j.wneu.2020.07.234
Vasquez CA, Downes A, Kleinschmidt-DeMasters BK, Youssef AS (2019) Functioning pituitary adenoma with xanthogranulomatous features: review of literature and case report. J Neurol Surg B Skull Base 80:449–457. https://doi.org/10.1055/s-0038-1675232
Stojanovic M, Manojlovic-Gacic E, Pekic S, Milojevic T, Miljic D, Doknic M, Nikolic Djurovic M, Jemuovic Z, Petakov M (2019) From diabetes insipidus to sellar xanthogranuloma - a “yellow brick road” demanding team-work. Acta Endocrinol (Buchar) 15:247–253. https://doi.org/10.4183/aeb.2019.247
Fujio S, Takajo T, Kinoshita Y, Hanaya R, Arimura H, Sugata J, Sugata S, Bohara M, Hiraki T, Yoshimoto K, Arita K (2019) Sellar xanthogranuloma: a quest based on nine cases assessed with an anterior pituitary provocation test. World Neurosurg 130:e150–e159. https://doi.org/10.1016/j.wneu.2019.06.021
Cho SM, Cho HR, Park YS, Chang HG (2018) Giant sellar xanthogranuloma after surgical treatment of symptomatic Rathke’s cleft cyst. Brain Tumor Res Treat 6:82–85. https://doi.org/10.14791/btrt.2018.6.e10
La Rocca G, Rigante M, Gessi M, D’Alessandris QG, Auricchio AM, Chiloiro S, De Marinis L, Lauretti L (2019) Xanthogranuloma of the sellar region: a rare tumor. Case illustration and literature review. J Clin Neurosci 59:318–324. https://doi.org/10.1016/j.jocn.2018.10.019
Kobayashi M, Yagasaki H, Kobayashi K, Ogiwara M, Kinouchi H, Sugita K (2018) Xanthogranuloma of the sellar region accompanied by growth hormone deficiency: case report and literature review. J Pediatr Endocrinol Metab 31:1161–1164. https://doi.org/10.1515/jpem-2018-0050
Nishimura F, Park YS, Motoyama Y, Nakagawa I, Yamada S, Nakase H (2018) Pediatric case of xanthogranuloma in the sellar region presenting a visual disturbance successfully treated with endoscopic endonasal surgery. World Neurosurg 114:22–26. https://doi.org/10.1016/j.wneu.2018.02.155
Ved R, Logier N, Leach P, Davies JS, Hayhurst C (2018) Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes. Pituitary 21:256–265. https://doi.org/10.1007/s11102-017-0859-x
Ji K, Zhang L, Wang L, Wang W (2016) Xanthogranuloma of the sellar region diagnosed by frozen section. Open Med (Wars) 11:426–428. https://doi.org/10.1515/med-2016-0076
Céspedes MT, Vargas JP, Yañez FA, León LS, Arancibia PÁ, Putz TS (2017) Remarkable diagnostic magnetic resonance imaging findings in sellar xanthogranuloma: report of three first cases in Latin America. J Neurol Surg Rep 78:e26–e33. https://doi.org/10.1055/s-0037-1598203
Mohanty S, Mohanty L, Bano S, Pattnaik K (2017) Xanthogranuloma (xg) masquerading as tumour of sellar region- a diagnostic challenge. Evid Based Med Healthc 4:4567–4570. https://doi.org/10.18410/jebmb/2017/912
Dai CX, Guo XS, Liu XH, Bao XJ, Feng M, Zhong DR, Ma WB, Wang RZ, Yao Y (2017) Xanthogranuloma of the sellar region. Chin Med J (Engl) 130:249–250. https://doi.org/10.4103/0366-6999
Hernández-Estrada RA, Kshettry VR, Vogel AN, Curtis MT, Evans JJ (2017) Cholesterol granulomas presenting as sellar masses: a similar, but clinically distinct entity from craniopharyngioma and Rathke’s cleft cyst. Pituitary 20:325–332. https://doi.org/10.1007/s11102-016-0775-5
Gurcay AG, Gurcan O, Kazanci A, Bozkurt I, Senturk S, Ferat M, Turkoglu OF, Beskonakli E, Orhun Yavuz HS (2016) Xanthogranuloma of the sellar region. Neurol India 64:1075–1079. https://doi.org/10.4103/0028-3886
Petrakakis I, Pirayesh A, Krauss JK, Raab P, Hartmann C, Nakamura M (2016) The sellar and suprasellar region: a “hideaway” of rare lesions. Clinical aspects, imaging findings, surgical outcome and comparative analysis. Clin Neurol Neurosurg 149:154–165. https://doi.org/10.1016/j.clineuro.2016.08.011
Ben Nsir A, Thai QA, Chaieb L, Jemel H (2015) Calcified suprasellar xanthogranuloma presenting with primary amenorrhea in a 17-year-old girl: case report and literature review. World Neurosurg 84:866.e11-866.e8.66E14. https://doi.org/10.1016/j.wneu.2015.04.024
Rahmani R, Sukumaran M, Donaldson AM, Akselrod O, Lavi E, Schwartz TH (2015) Parasellar xanthogranulomas. J Neurosurg 122:812–817. https://doi.org/10.3171/2014.12.JNS14542
Madan Mohan B, Mohamed E, Jain SK, Jain M, Jaiswal AK (2015) Serial MR imaging in suprasellar xanthogranuloma: growth pattern and new lesions. J Neuroimaging 25:677–679. https://doi.org/10.1111/jon.12170
Amano K, Kubo O, Komori T, Tanaka M, Kawamata T, Hori T, Okada Y (2013) Clinicopathological features of sellar region xanthogranuloma: correlation with Rathke’s cleft cyst. Brain Tumor Pathol 30:233–241. https://doi.org/10.1007/s10014-012-0130-0
Agarwal A, Agarwal K, Lee HK (2012) Xanthogranuloma of the sellar region a case report. Neuroradiol J 25:181–184. https://doi.org/10.1177/197140091202500204
Nishiuchi T, Murao K, Imachi H, Kushida Y, Haba R, Kawai N, Tamiya T, Ishida T (2012) Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report. J Med Case Rep 9(6):119. https://doi.org/10.1186/1752-1947-6-119
Tsai ST, Tsui YK, Wu MWL, Chen TY, Tzeng WS (2012) Xanthogranuloma of sellar region: a case report with diagnostic imaging findings, treatment response and literature review. J Radiol Sci 37:89–94
Kamoshima Y, Sawamura Y, Motegi H, Kubota K, Houkin K (2011) Xanthogranuloma of the sellar region of children: series of five cases and literature review. Neurol Med Chir (Tokyo) 51:689–693. https://doi.org/10.2176/nmc.51.689
Sulentić P, Cupić H, Cerina V, Vrkljan M (2010) Xanthogranuloma of the sellar region in a patient with sarcoidosis. Acta Clin Croat 49:61–65
Arai A, Nishihara M, Sasayama T, Aihara H, Hosoda K, Itoh T, Sakagami Y, Kuwamura K, Kohmura E (2010) Xanthogranuloma of the sellar region–case report. Neurol Med Chir (Tokyo) 50:488–491. https://doi.org/10.2176/nmc.50.488
Sugata S, Hirano H, Yatsushiro K, Yunoue S, Nakamura K, Arita K (2009) Xanthogranuloma in the suprasellar region. Neurol Med Chir (Tokyo) 49:124–127. https://doi.org/10.2176/nmc.49.124
Liu ZH, Tzaan WC, Wu YY, Chen HC (2008) Sellar xanthogranuloma manifesting as obstructive hydrocephalus. J Clin Neurosci 15:929–933. https://doi.org/10.1016/j.jocn.2007.05.028
Pavón de Paz I, Peñalver Talavera D, Olivar Roldán J, Carlos Gómez-Angulo Giner J, Santonja Garriga C, Monereo Megías S (2008) Sellar xanthogranuloma. Endocrinol Nutr 55:102–106. https://doi.org/10.1016/S1575-0922(08)70644-2
Tajima T, Sawamura Y, Ishizu K, Tsubaki J (2006) Two children with xanthogranuloma of the sellar region. Clin Pediatr Endocrinol 15:85–91. https://doi.org/10.1297/cpe.15.85
Jung CS, Schänzer A, Hattingen E, Plate KH, Seifert V (2006) Xanthogranuloma of the sellar region. Acta Neurochir (Wien) 148:473–477. https://doi.org/10.1007/s00701-005-0700-6
Burt MG, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK (2003) Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6:161–168. https://doi.org/10.1023/b:pitu.0000011177.43408.56
Yonezawa K, Shirataki K, Sakagami Y, Kohmura E (2003) Panhypopituitarism induced by cholesterol granuloma in the sellar region-case report. Neurol Med Chir (Tokyo) 43:259–262. https://doi.org/10.2176/nmc.43.259
Le BH, Towfighi J, Kapadia SB, Lopes MB (2007) Comparative immunohistochemical assessment of craniopharyngioma and related lesions. Endocr Pathol 18:23–30. https://doi.org/10.1007/s12022-007-0011-y
Duan K, Asa SL, Winer D, Gelareh Z, Gentili F, Mete O (2017) Xanthomatous hypophysitis is associated with ruptured Rathke’s cleft cyst. Endocr Pathol 28:83–90. https://doi.org/10.1007/s12022-017-9471-x
Nishioka H, Shibuya M, Ohtsuka K, Ikeda Y, Haraoka J (2010) Endocrinological and MRI features of pituitary adenomas with marked xanthogranulomatous reaction. Neuroradiology 52:997–1002. https://doi.org/10.1007/s00234-010-0675-8
Türe U, De Bellis A, Harput MV, Bellastella G, Topcuoglu M, Yaltirik CK, Cirillo P, Yola RN, Sav A, Kelestimur F (2021) Hypothalamitis: a novel autoimmune endocrine disease. A literature review and case report. J Clin Endocrinol Metab 106(2):e415–e429. https://doi.org/10.1210/clinem/dgaa771
Yang B, Yang C, Fang J, Li G, Wang J, Jia G, Liu P, Jia W, Wang S (2017) Clinicoradiologic features and surgical outcomes of sellar xanthogranulomas: a single-center 10-year experience. World Neurosurg 99:439–447. https://doi.org/10.1016/j.wneu.2016.12.017
Author information
Authors and Affiliations
Contributions
FG-P and CV (conceived the study and wrote original draft); FG-P, APM, and NV (acquisition and curation of data); FG-P, APM, NV, and NRR (analysis and interpretation of data); and JJSF, JLS, ATD, and MPM (critical revision of manuscript). All authors have read and agreed to publish the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Guerrero-Pérez, F., Marengo, A.P., Vilarrasa, N. et al. Xanthogranuloma of the sellar region: a systematic review. Hormones 22, 199–210 (2023). https://doi.org/10.1007/s42000-023-00432-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42000-023-00432-y